Compare Johnson & Johnson (JNJ) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while Direxion Daily TSLA Bull 2X Shares trades at $8.02. The key difference: Johnson & Johnson pays a 2.06% dividend while Direxion Daily TSLA Bull 2X Shares pays none, and Johnson & Johnson is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| JNJ | TSLL | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $267.24 | $23.03 |
52-Week Low | $172.78 | $6.74 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $8.05, down 1.95% on the day. The technical outlook is bearish, with moving averages signaling a downtrend and key support at $8. Recent news highlights the amplified volatility inherent in this leveraged Tesla ETF, as discussed by 24/7 Wall Street on July 31, 2026.
The outlook for TSLL is heavily dependent on the performance of Tesla stock, with significant risk from daily leverage decay and market volatility. Investment opportunity exists for those betting on short-term Tesla gains, but the structure poses substantial risk of loss even if Tesla's price increases over the long term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
